Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era. [electronic resource]
Producer: 20200604Description: 993-1000 p. digitalISSN:- 1473-5571
- Adult
- Anti-Retroviral Agents -- therapeutic use
- Antibodies, Viral -- blood
- Biomarkers -- blood
- DNA, Viral -- blood
- Epstein-Barr Virus Infections -- complications
- Female
- HIV Infections -- complications
- Herpesvirus 4, Human -- genetics
- Hodgkin Disease -- diagnosis
- Humans
- Male
- Prognosis
- Prospective Studies
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.